

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.00076774 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.00076774 |
| 3 | oxygen transport (GO:0015671) | 4.47231137 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.45631175 |
| 5 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.35986729 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.20066755 |
| 7 | negative regulation of cell size (GO:0045792) | 4.09889014 |
| 8 | plasma membrane repair (GO:0001778) | 4.07155879 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.01958242 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.01958242 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.01958242 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.01958242 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.01958242 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.01958242 |
| 15 | negative regulation of necroptotic process (GO:0060546) | 4.01214200 |
| 16 | hemoglobin metabolic process (GO:0020027) | 3.99072495 |
| 17 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.96302692 |
| 18 | regulation of necroptotic process (GO:0060544) | 3.95042449 |
| 19 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.91533036 |
| 20 | peptidyl-lysine dimethylation (GO:0018027) | 3.88060801 |
| 21 | regulation of hippo signaling (GO:0035330) | 3.87393660 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76380740 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74843307 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74360835 |
| 25 | erythrocyte development (GO:0048821) | 3.72800322 |
| 26 | gas transport (GO:0015669) | 3.70500561 |
| 27 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.66564891 |
| 28 | lysine metabolic process (GO:0006553) | 3.57557499 |
| 29 | lysine catabolic process (GO:0006554) | 3.57557499 |
| 30 | detection of other organism (GO:0098543) | 3.48462084 |
| 31 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.48075837 |
| 32 | carnitine shuttle (GO:0006853) | 3.47121019 |
| 33 | positive regulation of receptor recycling (GO:0001921) | 3.42033879 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40503212 |
| 35 | leukocyte aggregation (GO:0070486) | 3.35746677 |
| 36 | histone H3-K36 demethylation (GO:0070544) | 3.33535014 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.32556821 |
| 38 | detection of bacterium (GO:0016045) | 3.30956047 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28429209 |
| 40 | hepatocyte apoptotic process (GO:0097284) | 3.27857591 |
| 41 | cardiac myofibril assembly (GO:0055003) | 3.24793459 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24208994 |
| 43 | negative regulation of necrotic cell death (GO:0060547) | 3.23822951 |
| 44 | regulation of platelet aggregation (GO:0090330) | 3.21652072 |
| 45 | sarcomere organization (GO:0045214) | 3.21073562 |
| 46 | adherens junction assembly (GO:0034333) | 3.17763374 |
| 47 | pre-miRNA processing (GO:0031054) | 3.17697020 |
| 48 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.15715014 |
| 49 | modulation by virus of host process (GO:0019054) | 3.14898920 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14831658 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14212506 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13586799 |
| 53 | fatty acid transmembrane transport (GO:1902001) | 3.11646442 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.10643632 |
| 55 | regulation of cholesterol homeostasis (GO:2000188) | 3.09290018 |
| 56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08658425 |
| 57 | response to peptidoglycan (GO:0032494) | 3.06236016 |
| 58 | maternal placenta development (GO:0001893) | 3.05504480 |
| 59 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.04665322 |
| 60 | modulation by symbiont of host cellular process (GO:0044068) | 3.04320203 |
| 61 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.03574905 |
| 62 | regulation of necrotic cell death (GO:0010939) | 3.01598109 |
| 63 | detection of external biotic stimulus (GO:0098581) | 3.00923227 |
| 64 | detection of molecule of bacterial origin (GO:0032490) | 2.99976645 |
| 65 | positive regulation of histone deacetylation (GO:0031065) | 2.99775364 |
| 66 | protein localization to endosome (GO:0036010) | 2.99465667 |
| 67 | focal adhesion assembly (GO:0048041) | 2.98102397 |
| 68 | cell-substrate adherens junction assembly (GO:0007045) | 2.98102397 |
| 69 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.96749493 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 2.96009711 |
| 71 | aspartate family amino acid catabolic process (GO:0009068) | 2.95077090 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93025620 |
| 73 | positive regulation of nuclease activity (GO:0032075) | 2.92576886 |
| 74 | polarized epithelial cell differentiation (GO:0030859) | 2.92224222 |
| 75 | carnitine transmembrane transport (GO:1902603) | 2.91094049 |
| 76 | cellular extravasation (GO:0045123) | 2.91042762 |
| 77 | cellular response to virus (GO:0098586) | 2.90896220 |
| 78 | regulation of response to osmotic stress (GO:0047484) | 2.90306630 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 2.89556640 |
| 80 | regulation of p38MAPK cascade (GO:1900744) | 2.89335360 |
| 81 | myeloid cell development (GO:0061515) | 2.89242077 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.88638204 |
| 83 | 4-hydroxyproline metabolic process (GO:0019471) | 2.87375771 |
| 84 | amino-acid betaine transport (GO:0015838) | 2.86551303 |
| 85 | carnitine transport (GO:0015879) | 2.86551303 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86495002 |
| 87 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.84573266 |
| 88 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84355901 |
| 89 | erythrocyte maturation (GO:0043249) | 2.83641990 |
| 90 | regulation of translational fidelity (GO:0006450) | 2.83244611 |
| 91 | epithelial cell-cell adhesion (GO:0090136) | 2.82119987 |
| 92 | regulation of translational termination (GO:0006449) | 2.80644988 |
| 93 | stress fiber assembly (GO:0043149) | 2.79542185 |
| 94 | paraxial mesoderm development (GO:0048339) | 2.77687944 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77394995 |
| 96 | response to muramyl dipeptide (GO:0032495) | 2.76560158 |
| 97 | germinal center formation (GO:0002467) | 2.75289182 |
| 98 | cell-substrate junction assembly (GO:0007044) | 2.75156508 |
| 99 | regulation of regulated secretory pathway (GO:1903305) | 2.74079703 |
| 100 | response to interleukin-15 (GO:0070672) | 2.73980241 |
| 101 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.73051818 |
| 102 | 2-oxoglutarate metabolic process (GO:0006103) | 2.72939795 |
| 103 | negative regulation of heart growth (GO:0061117) | 2.72040313 |
| 104 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.72040313 |
| 105 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71187610 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70612590 |
| 107 | response to host immune response (GO:0052572) | 2.70612590 |
| 108 | respiratory burst (GO:0045730) | 2.69214054 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67823926 |
| 110 | response to host (GO:0075136) | 2.67823926 |
| 111 | response to host defenses (GO:0052200) | 2.67823926 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 2.66431117 |
| 113 | heterochromatin organization (GO:0070828) | 2.65318776 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.65181044 |
| 115 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.64817392 |
| 116 | microglial cell activation (GO:0001774) | 2.64256977 |
| 117 | B cell receptor signaling pathway (GO:0050853) | 2.63849937 |
| 118 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63664238 |
| 119 | neutrophil mediated immunity (GO:0002446) | 2.63602157 |
| 120 | cellular response to epinephrine stimulus (GO:0071872) | 2.62622373 |
| 121 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60615846 |
| 122 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.60139081 |
| 123 | hippo signaling (GO:0035329) | 2.59322335 |
| 124 | protein hydroxylation (GO:0018126) | 2.58476977 |
| 125 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58368799 |
| 126 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.58284749 |
| 127 | regulation of fatty acid oxidation (GO:0046320) | 2.57920949 |
| 128 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.57066915 |
| 129 | NLS-bearing protein import into nucleus (GO:0006607) | 2.57046089 |
| 130 | regulation of nuclease activity (GO:0032069) | 2.56693356 |
| 131 | low-density lipoprotein particle clearance (GO:0034383) | 2.56601325 |
| 132 | myofibril assembly (GO:0030239) | 2.55905645 |
| 133 | detection of biotic stimulus (GO:0009595) | 2.55899128 |
| 134 | neutrophil activation (GO:0042119) | 2.55773017 |
| 135 | histone H3-K9 demethylation (GO:0033169) | 2.55405011 |
| 136 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.55265771 |
| 137 | creatine metabolic process (GO:0006600) | 2.53553490 |
| 138 | macrophage activation (GO:0042116) | 2.51063179 |
| 139 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.50995757 |
| 140 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.50423366 |
| 141 | positive regulation of Rap GTPase activity (GO:0032854) | 2.49979695 |
| 142 | mRNA stabilization (GO:0048255) | 2.49790964 |
| 143 | RNA stabilization (GO:0043489) | 2.49790964 |
| 144 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.49565814 |
| 145 | cellular hyperosmotic response (GO:0071474) | 2.49111603 |
| 146 | negative regulation of myotube differentiation (GO:0010832) | 2.48785305 |
| 147 | tricarboxylic acid cycle (GO:0006099) | 2.48182690 |
| 148 | establishment of apical/basal cell polarity (GO:0035089) | 2.47800826 |
| 149 | alpha-linolenic acid metabolic process (GO:0036109) | 2.45548340 |
| 150 | regulation of tight junction assembly (GO:2000810) | 2.45147607 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.45022222 |
| 152 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.44426746 |
| 153 | granulocyte activation (GO:0036230) | 2.43340121 |
| 154 | negative regulation of phagocytosis (GO:0050765) | 2.43148100 |
| 155 | histone lysine demethylation (GO:0070076) | 2.42953221 |
| 156 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.42753950 |
| 157 | positive regulation of fibroblast migration (GO:0010763) | 2.42605566 |
| 158 | positive T cell selection (GO:0043368) | 2.41448267 |
| 159 | regulation of defense response to virus by virus (GO:0050690) | 2.41366612 |
| 160 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.41195676 |
| 161 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.40640450 |
| 162 | thymic T cell selection (GO:0045061) | 2.40051616 |
| 163 | pentose-phosphate shunt (GO:0006098) | 2.39407371 |
| 164 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.39320840 |
| 165 | negative regulation of fatty acid transport (GO:2000192) | 2.39082919 |
| 166 | growth hormone secretion (GO:0030252) | 2.38058766 |
| 167 | peptidyl-proline hydroxylation (GO:0019511) | 2.37091374 |
| 168 | cell communication involved in cardiac conduction (GO:0086065) | 2.36820626 |
| 169 | cardiac muscle cell development (GO:0055013) | 2.36034456 |
| 170 | cell communication by electrical coupling (GO:0010644) | 2.35251200 |
| 171 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.33620485 |
| 172 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.32627716 |
| 173 | actomyosin structure organization (GO:0031032) | 2.31803538 |
| 174 | tricarboxylic acid metabolic process (GO:0072350) | 2.31750376 |
| 175 | apoptotic cell clearance (GO:0043277) | 2.31458206 |
| 176 | protein targeting to plasma membrane (GO:0072661) | 2.29166461 |
| 177 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.27992903 |
| 178 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.27803194 |
| 179 | ER-nucleus signaling pathway (GO:0006984) | 2.27529694 |
| 180 | cellular response to unfolded protein (GO:0034620) | 2.27434099 |
| 181 | cardiac muscle contraction (GO:0060048) | 2.25517693 |
| 182 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.24908203 |
| 183 | negative regulation of lipid transport (GO:0032369) | 2.24521893 |
| 184 | muscle filament sliding (GO:0030049) | 2.23935025 |
| 185 | actin-myosin filament sliding (GO:0033275) | 2.23935025 |
| 186 | heart trabecula formation (GO:0060347) | 2.23898925 |
| 187 | tetrapyrrole biosynthetic process (GO:0033014) | 2.22387237 |
| 188 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.21613768 |
| 189 | acetyl-CoA metabolic process (GO:0006084) | 2.19969855 |
| 190 | sodium ion export (GO:0071436) | 2.19894572 |
| 191 | regulation of cardioblast differentiation (GO:0051890) | 2.19876556 |
| 192 | quaternary ammonium group transport (GO:0015697) | 2.19726328 |
| 193 | Golgi transport vesicle coating (GO:0048200) | 2.18774399 |
| 194 | COPI coating of Golgi vesicle (GO:0048205) | 2.18774399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.92341766 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.89484863 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.85846815 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.84293777 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63710192 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.49808551 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.46799939 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.35806786 |
| 9 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.28981815 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27984692 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.27576619 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26187899 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.26133824 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24760313 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.24100959 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22868244 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21871698 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18880811 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15107932 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13303514 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.13251407 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06790268 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 2.02053006 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01338862 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99399398 |
| 26 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.96818937 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96722385 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95395754 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.94867223 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94364719 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94134415 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92363412 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88753848 |
| 34 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88175949 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87964678 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86919019 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86830299 |
| 38 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.86697116 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85418050 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85384019 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82549642 |
| 42 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.80187601 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76756206 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.75777231 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.73803239 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.73311268 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73115837 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71999109 |
| 49 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70213020 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.68946827 |
| 51 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.66508153 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.65387033 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.65253956 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64371626 |
| 55 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.62470960 |
| 56 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.61842633 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59940493 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59470106 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.59294933 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58730560 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57052880 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56703205 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55756145 |
| 64 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.54185460 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.53968816 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52953256 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52676843 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.51814225 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51172164 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51023826 |
| 71 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.46969535 |
| 72 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.46721695 |
| 73 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45003476 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45003476 |
| 75 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44168729 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41306975 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40477393 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39780705 |
| 79 | MYB_26560356_Chip-Seq_TH1_Human | 1.39625248 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39213929 |
| 81 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38508572 |
| 82 | * MYB_26560356_Chip-Seq_TH2_Human | 1.37353910 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36945136 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34777734 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34665093 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32780577 |
| 87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.32545453 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32447294 |
| 89 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31567552 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.30940266 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30896965 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30861270 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30158056 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28000869 |
| 95 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26531770 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26278695 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26132735 |
| 98 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26129719 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25775426 |
| 100 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.24949329 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23432809 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22996865 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22906590 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22760297 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22629897 |
| 106 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22551196 |
| 107 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.21087586 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20153314 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18640047 |
| 110 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18194524 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17778481 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17106746 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16748069 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16291439 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15316906 |
| 116 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14976252 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13809568 |
| 118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12151803 |
| 119 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10921796 |
| 120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10808919 |
| 121 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.10706358 |
| 122 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09805314 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09527886 |
| 124 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08745736 |
| 125 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08613592 |
| 126 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08548789 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08539077 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08384753 |
| 129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07239487 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06838324 |
| 131 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06617122 |
| 132 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06547551 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05747493 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04418544 |
| 135 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.04412046 |
| 136 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03910886 |
| 137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02109257 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.02049856 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01690004 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01620966 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01284673 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00367830 |
| 143 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00072048 |
| 144 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99960118 |
| 145 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99929005 |
| 146 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99081658 |
| 147 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.97640409 |
| 148 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97207744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008260_abnormal_autophagy | 4.45676488 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.25366086 |
| 3 | MP0005451_abnormal_body_composition | 4.13746785 |
| 4 | MP0003436_decreased_susceptibility_to | 3.10015873 |
| 5 | MP0003724_increased_susceptibility_to | 2.96420620 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.96109789 |
| 7 | MP0003646_muscle_fatigue | 2.68155219 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.64595968 |
| 9 | MP0000751_myopathy | 2.62018215 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.51798155 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.18715850 |
| 12 | MP0004510_myositis | 2.16776404 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.15510152 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.10221614 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.08601697 |
| 16 | MP0003878_abnormal_ear_physiology | 2.08601697 |
| 17 | MP0004130_abnormal_muscle_cell | 2.08511209 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.07439311 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.07284028 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.02642427 |
| 21 | MP0008961_abnormal_basal_metabolism | 2.02024985 |
| 22 | MP0004087_abnormal_muscle_fiber | 2.01969524 |
| 23 | MP0004233_abnormal_muscle_weight | 2.00862743 |
| 24 | MP0002419_abnormal_innate_immunity | 1.96656375 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.95839721 |
| 26 | MP0003828_pulmonary_edema | 1.91667173 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.86774579 |
| 28 | MP0005083_abnormal_biliary_tract | 1.86714982 |
| 29 | MP0003283_abnormal_digestive_organ | 1.84941642 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.81044970 |
| 31 | MP0005025_abnormal_response_to | 1.79928101 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.77427117 |
| 33 | MP0000685_abnormal_immune_system | 1.76842181 |
| 34 | MP0001849_ear_inflammation | 1.76533973 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.72625077 |
| 36 | MP0005330_cardiomyopathy | 1.71516161 |
| 37 | MP0000747_muscle_weakness | 1.71239056 |
| 38 | MP0002269_muscular_atrophy | 1.68683633 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.68146730 |
| 40 | MP0000750_abnormal_muscle_regeneration | 1.66955779 |
| 41 | MP0004947_skin_inflammation | 1.65137024 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.62704582 |
| 43 | MP0000749_muscle_degeneration | 1.61664485 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.61133205 |
| 45 | MP0000733_abnormal_muscle_development | 1.59394045 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.58624133 |
| 47 | MP0002398_abnormal_bone_marrow | 1.58540514 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.57099141 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.56298801 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.56079031 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.55925850 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.55925850 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.55042109 |
| 54 | MP0001800_abnormal_humoral_immune | 1.53367919 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.52162984 |
| 56 | MP0001819_abnormal_immune_cell | 1.52084008 |
| 57 | MP0000759_abnormal_skeletal_muscle | 1.47350643 |
| 58 | MP0001790_abnormal_immune_system | 1.46920109 |
| 59 | MP0005387_immune_system_phenotype | 1.46920109 |
| 60 | MP0004147_increased_porphyrin_level | 1.43344939 |
| 61 | MP0004858_abnormal_nervous_system | 1.41241537 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.41189725 |
| 63 | MP0000537_abnormal_urethra_morphology | 1.40490030 |
| 64 | MP0002723_abnormal_immune_serum | 1.38246879 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.36406736 |
| 66 | MP0002405_respiratory_system_inflammati | 1.36020408 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.33568207 |
| 68 | MP0003091_abnormal_cell_migration | 1.33374405 |
| 69 | MP0002106_abnormal_muscle_physiology | 1.32113673 |
| 70 | MP0002722_abnormal_immune_system | 1.31507635 |
| 71 | MP0009278_abnormal_bone_marrow | 1.31465409 |
| 72 | MP0008775_abnormal_heart_ventricle | 1.30951985 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.30385160 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.30359071 |
| 75 | MP0005670_abnormal_white_adipose | 1.30286294 |
| 76 | MP0005360_urolithiasis | 1.28904355 |
| 77 | MP0006138_congestive_heart_failure | 1.28546890 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.28155215 |
| 79 | MP0009785_altered_susceptibility_to | 1.27453017 |
| 80 | MP0000858_altered_metastatic_potential | 1.26693555 |
| 81 | MP0000716_abnormal_immune_system | 1.25768840 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.25618688 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25452237 |
| 84 | MP0009672_abnormal_birth_weight | 1.23421831 |
| 85 | MP0002796_impaired_skin_barrier | 1.21844139 |
| 86 | MP0009053_abnormal_anal_canal | 1.21551119 |
| 87 | MP0000003_abnormal_adipose_tissue | 1.20847049 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.20746267 |
| 89 | MP0004381_abnormal_hair_follicle | 1.20639700 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 1.19796049 |
| 91 | MP0005620_abnormal_muscle_contractility | 1.19028834 |
| 92 | MP0009840_abnormal_foam_cell | 1.17377748 |
| 93 | MP0004215_abnormal_myocardial_fiber | 1.16723103 |
| 94 | MP0002429_abnormal_blood_cell | 1.16389453 |
| 95 | MP0003119_abnormal_digestive_system | 1.15499195 |
| 96 | MP0002234_abnormal_pharynx_morphology | 1.15355892 |
| 97 | MP0003303_peritoneal_inflammation | 1.15344633 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 1.14880667 |
| 99 | MP0001730_embryonic_growth_arrest | 1.14427348 |
| 100 | MP0003866_abnormal_defecation | 1.13547923 |
| 101 | MP0001544_abnormal_cardiovascular_syste | 1.13459671 |
| 102 | MP0005385_cardiovascular_system_phenoty | 1.13459671 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 1.12541678 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 1.11525994 |
| 105 | MP0002084_abnormal_developmental_patter | 1.11378068 |
| 106 | MP0002972_abnormal_cardiac_muscle | 1.10193909 |
| 107 | MP0005275_abnormal_skin_tensile | 1.10144103 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 1.09829362 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 1.08102883 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 1.07827889 |
| 111 | MP0005365_abnormal_bile_salt | 1.06676523 |
| 112 | MP0002909_abnormal_adrenal_gland | 1.05243709 |
| 113 | MP0004484_altered_response_of | 1.04480258 |
| 114 | MP0001851_eye_inflammation | 1.04393360 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 1.04129797 |
| 116 | MP0005085_abnormal_gallbladder_physiolo | 1.03841472 |
| 117 | MP0010329_abnormal_lipoprotein_level | 1.03431097 |
| 118 | MP0003984_embryonic_growth_retardation | 1.03300249 |
| 119 | MP0000266_abnormal_heart_morphology | 1.03211184 |
| 120 | MP0003115_abnormal_respiratory_system | 1.02954346 |
| 121 | MP0002088_abnormal_embryonic_growth/wei | 1.02862373 |
| 122 | MP0010155_abnormal_intestine_physiology | 1.02353314 |
| 123 | MP0005369_muscle_phenotype | 1.00571526 |
| 124 | MP0001672_abnormal_embryogenesis/_devel | 1.00258576 |
| 125 | MP0005380_embryogenesis_phenotype | 1.00258576 |
| 126 | MP0008874_decreased_physiological_sensi | 0.98399809 |
| 127 | MP0004272_abnormal_basement_membrane | 0.98337935 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.97101783 |
| 129 | MP0002085_abnormal_embryonic_tissue | 0.97002360 |
| 130 | MP0003183_abnormal_peptide_metabolism | 0.96573369 |
| 131 | MP0002132_abnormal_respiratory_system | 0.96035134 |
| 132 | MP0002086_abnormal_extraembryonic_tissu | 0.95516397 |
| 133 | MP0005187_abnormal_penis_morphology | 0.92815461 |
| 134 | MP0005501_abnormal_skin_physiology | 0.92443900 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.92333980 |
| 136 | MP0003252_abnormal_bile_duct | 0.91264230 |
| 137 | MP0008770_decreased_survivor_rate | 0.91082431 |
| 138 | MP0005310_abnormal_salivary_gland | 0.90863136 |
| 139 | MP0004883_abnormal_blood_vessel | 0.89422201 |
| 140 | MP0005621_abnormal_cell_physiology | 0.89223414 |
| 141 | MP0002925_abnormal_cardiovascular_devel | 0.89093850 |
| 142 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89078533 |
| 143 | MP0003690_abnormal_glial_cell | 0.87870365 |
| 144 | MP0010030_abnormal_orbit_morphology | 0.87323864 |
| 145 | MP0002089_abnormal_postnatal_growth/wei | 0.86986276 |
| 146 | MP0000604_amyloidosis | 0.86485593 |
| 147 | MP0001697_abnormal_embryo_size | 0.86146075 |
| 148 | MP0004085_abnormal_heartbeat | 0.85702729 |
| 149 | MP0002998_abnormal_bone_remodeling | 0.85137644 |
| 150 | MP0006082_CNS_inflammation | 0.83110243 |
| 151 | MP0003075_altered_response_to | 0.81504871 |
| 152 | MP0003329_amyloid_beta_deposits | 0.80710926 |
| 153 | MP0003137_abnormal_impulse_conducting | 0.80346576 |
| 154 | MP0003045_fibrosis | 0.79217936 |
| 155 | MP0008004_abnormal_stomach_pH | 0.78972034 |
| 156 | MP0002896_abnormal_bone_mineralization | 0.78921902 |
| 157 | MP0000609_abnormal_liver_physiology | 0.78343882 |
| 158 | MP0002080_prenatal_lethality | 0.78110113 |
| 159 | MP0000534_abnormal_ureter_morphology | 0.77483741 |
| 160 | MP0002148_abnormal_hypersensitivity_rea | 0.76875203 |
| 161 | MP0010368_abnormal_lymphatic_system | 0.75005851 |
| 162 | MP0005167_abnormal_blood-brain_barrier | 0.74732784 |
| 163 | MP0002971_abnormal_brown_adipose | 0.74536598 |
| 164 | MP0003279_aneurysm | 0.73707831 |
| 165 | MP0008469_abnormal_protein_level | 0.73198944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 5.26366393 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.38766365 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.27912095 |
| 4 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.94997370 |
| 5 | Increased connective tissue (HP:0009025) | 3.63228196 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 3.57313616 |
| 7 | Microcytic anemia (HP:0001935) | 3.49034256 |
| 8 | Hypochromic anemia (HP:0001931) | 3.47825225 |
| 9 | Sudden death (HP:0001699) | 3.43047897 |
| 10 | Exercise-induced myalgia (HP:0003738) | 3.39720703 |
| 11 | Difficulty running (HP:0009046) | 3.36412008 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.33178158 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.27319918 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.19291446 |
| 15 | Difficulty climbing stairs (HP:0003551) | 3.18084008 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.10706931 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.08684421 |
| 18 | Slow saccadic eye movements (HP:0000514) | 3.07670300 |
| 19 | Muscle fiber splitting (HP:0003555) | 3.06822270 |
| 20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.06305480 |
| 21 | Myoglobinuria (HP:0002913) | 3.03617012 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 3.01500139 |
| 23 | Nemaline bodies (HP:0003798) | 2.97420794 |
| 24 | Cerebral aneurysm (HP:0004944) | 2.95716086 |
| 25 | Ventricular tachycardia (HP:0004756) | 2.91825866 |
| 26 | Unilateral renal agenesis (HP:0000122) | 2.88412761 |
| 27 | Insomnia (HP:0100785) | 2.88353952 |
| 28 | Myositis (HP:0100614) | 2.88188713 |
| 29 | Cholecystitis (HP:0001082) | 2.85884780 |
| 30 | Abnormal gallbladder physiology (HP:0012438) | 2.85884780 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 2.84682028 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.83764164 |
| 33 | Lymphangioma (HP:0100764) | 2.83331687 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.81607703 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.81607703 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.79630007 |
| 37 | Back pain (HP:0003418) | 2.76981988 |
| 38 | Reticulocytosis (HP:0001923) | 2.76251910 |
| 39 | Hyperacusis (HP:0010780) | 2.71871657 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.69793075 |
| 41 | Protrusio acetabuli (HP:0003179) | 2.66725793 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 2.66559749 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.65146967 |
| 44 | Gingivitis (HP:0000230) | 2.65135322 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.64692461 |
| 46 | Distal lower limb amyotrophy (HP:0008944) | 2.64520808 |
| 47 | Shallow orbits (HP:0000586) | 2.63990158 |
| 48 | Bundle branch block (HP:0011710) | 2.63971645 |
| 49 | Orchitis (HP:0100796) | 2.61910122 |
| 50 | Hand muscle atrophy (HP:0009130) | 2.60848389 |
| 51 | Cellulitis (HP:0100658) | 2.59867503 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.56650276 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54445469 |
| 54 | Atrioventricular block (HP:0001678) | 2.51522030 |
| 55 | Poikilocytosis (HP:0004447) | 2.50497350 |
| 56 | Polycythemia (HP:0001901) | 2.50209904 |
| 57 | Urticaria (HP:0001025) | 2.45593788 |
| 58 | Rectal prolapse (HP:0002035) | 2.41005177 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40724046 |
| 60 | Obstructive lung disease (HP:0006536) | 2.40724046 |
| 61 | Cholelithiasis (HP:0001081) | 2.40202856 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.39131927 |
| 63 | Alopecia of scalp (HP:0002293) | 2.38041822 |
| 64 | Chest pain (HP:0100749) | 2.37364701 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.32201761 |
| 66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.29534897 |
| 67 | Ependymoma (HP:0002888) | 2.28912892 |
| 68 | Increased IgE level (HP:0003212) | 2.27814355 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25995453 |
| 70 | Toxemia of pregnancy (HP:0100603) | 2.25664988 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.23745805 |
| 72 | Gingival bleeding (HP:0000225) | 2.21061617 |
| 73 | Scapular winging (HP:0003691) | 2.21013827 |
| 74 | Dysmetric saccades (HP:0000641) | 2.18710709 |
| 75 | EMG: neuropathic changes (HP:0003445) | 2.18653162 |
| 76 | Abnormal hemoglobin (HP:0011902) | 2.17686322 |
| 77 | Epistaxis (HP:0000421) | 2.17405102 |
| 78 | Optic neuritis (HP:0100653) | 2.17291335 |
| 79 | Retrobulbar optic neuritis (HP:0100654) | 2.17291335 |
| 80 | Ankle contracture (HP:0006466) | 2.15421119 |
| 81 | Aneurysm (HP:0002617) | 2.15009774 |
| 82 | Elfin facies (HP:0004428) | 2.14248650 |
| 83 | Obstructive sleep apnea (HP:0002870) | 2.13347879 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 2.12192258 |
| 85 | Genu recurvatum (HP:0002816) | 2.12149225 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.11588633 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 2.11455107 |
| 88 | Abnormal atrioventricular conduction (HP:0005150) | 2.10699109 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.10433947 |
| 90 | Rhabdomyolysis (HP:0003201) | 2.10165859 |
| 91 | Heart block (HP:0012722) | 2.10053195 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09475695 |
| 93 | EMG: myopathic abnormalities (HP:0003458) | 2.07964030 |
| 94 | Deep venous thrombosis (HP:0002625) | 2.07641065 |
| 95 | Peritonitis (HP:0002586) | 2.07447304 |
| 96 | Mediastinal lymphadenopathy (HP:0100721) | 2.06664826 |
| 97 | Subaortic stenosis (HP:0001682) | 2.05277936 |
| 98 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05277936 |
| 99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.05118756 |
| 100 | Premature rupture of membranes (HP:0001788) | 2.02898943 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.02860503 |
| 102 | Pseudobulbar signs (HP:0002200) | 2.02842043 |
| 103 | Abnormal gallbladder morphology (HP:0012437) | 2.02534675 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 2.02032838 |
| 105 | Myopathic facies (HP:0002058) | 2.02002684 |
| 106 | Ventricular fibrillation (HP:0001663) | 1.99990812 |
| 107 | Meningitis (HP:0001287) | 1.98989248 |
| 108 | Gout (HP:0001997) | 1.98823234 |
| 109 | Broad metatarsal (HP:0001783) | 1.97896985 |
| 110 | Stomatitis (HP:0010280) | 1.97697541 |
| 111 | Abnormality of the foot musculature (HP:0001436) | 1.96979380 |
| 112 | Astrocytoma (HP:0009592) | 1.95181032 |
| 113 | Abnormality of the astrocytes (HP:0100707) | 1.95181032 |
| 114 | Ulnar bowing (HP:0003031) | 1.94832200 |
| 115 | Renal duplication (HP:0000075) | 1.93907059 |
| 116 | Enlarged penis (HP:0000040) | 1.93276426 |
| 117 | Renovascular hypertension (HP:0100817) | 1.92303265 |
| 118 | Abnormality of the calf musculature (HP:0001430) | 1.92227473 |
| 119 | Round ear (HP:0100830) | 1.91463214 |
| 120 | Fatigue (HP:0012378) | 1.90987396 |
| 121 | Bladder diverticulum (HP:0000015) | 1.90954629 |
| 122 | Recurrent skin infections (HP:0001581) | 1.89856456 |
| 123 | Ketoacidosis (HP:0001993) | 1.89818379 |
| 124 | Ankle clonus (HP:0011448) | 1.89505976 |
| 125 | Calf muscle hypertrophy (HP:0008981) | 1.88916915 |
| 126 | Easy fatigability (HP:0003388) | 1.87414391 |
| 127 | Pustule (HP:0200039) | 1.87100332 |
| 128 | Ketosis (HP:0001946) | 1.85216363 |
| 129 | Osteomyelitis (HP:0002754) | 1.83759664 |
| 130 | Mitral valve prolapse (HP:0001634) | 1.83719480 |
| 131 | Turricephaly (HP:0000262) | 1.82011636 |
| 132 | Ventricular arrhythmia (HP:0004308) | 1.81597622 |
| 133 | Ulnar deviation of the wrist (HP:0003049) | 1.81285279 |
| 134 | Termporal pattern (HP:0011008) | 1.80988383 |
| 135 | Insidious onset (HP:0003587) | 1.80988383 |
| 136 | Spinal rigidity (HP:0003306) | 1.80552972 |
| 137 | Frequent falls (HP:0002359) | 1.80252854 |
| 138 | Abnormal platelet volume (HP:0011876) | 1.79941560 |
| 139 | Decreased motor nerve conduction velocity (HP:0003431) | 1.78819441 |
| 140 | Male infertility (HP:0003251) | 1.77177382 |
| 141 | Vasculitis (HP:0002633) | 1.77133613 |
| 142 | Long toe (HP:0010511) | 1.76055629 |
| 143 | Global brain atrophy (HP:0002283) | 1.75921904 |
| 144 | Muscle fiber inclusion bodies (HP:0100299) | 1.75797600 |
| 145 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.74784015 |
| 146 | Neck muscle weakness (HP:0000467) | 1.74435382 |
| 147 | Hamartoma of the eye (HP:0010568) | 1.74097932 |
| 148 | Adenoma sebaceum (HP:0009720) | 1.73537509 |
| 149 | Angiofibromas (HP:0010615) | 1.73537509 |
| 150 | Broad face (HP:0000283) | 1.73437466 |
| 151 | Increased serum ferritin (HP:0003281) | 1.73313811 |
| 152 | Postural instability (HP:0002172) | 1.73158224 |
| 153 | Metaphyseal cupping (HP:0003021) | 1.72590978 |
| 154 | Arterial thrombosis (HP:0004420) | 1.72450832 |
| 155 | Lipoatrophy (HP:0100578) | 1.72393940 |
| 156 | Fibroma (HP:0010614) | 1.72312633 |
| 157 | Episodic fever (HP:0001954) | 1.71346899 |
| 158 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.70947252 |
| 159 | Late onset (HP:0003584) | 1.70898913 |
| 160 | Rapidly progressive (HP:0003678) | 1.70723833 |
| 161 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.70622061 |
| 162 | Keratoconjunctivitis sicca (HP:0001097) | 1.70338030 |
| 163 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.70271253 |
| 164 | Follicular hyperkeratosis (HP:0007502) | 1.70121893 |
| 165 | Atrial fibrillation (HP:0005110) | 1.70074935 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.69313321 |
| 167 | Amyloidosis (HP:0011034) | 1.69149803 |
| 168 | Diaphragmatic weakness (HP:0009113) | 1.68534714 |
| 169 | Limb-girdle muscle weakness (HP:0003325) | 1.68222171 |
| 170 | Abnormality of iron homeostasis (HP:0011031) | 1.67682773 |
| 171 | Subacute progressive viral hepatitis (HP:0006572) | 1.67298940 |
| 172 | Muscle stiffness (HP:0003552) | 1.67146235 |
| 173 | Encephalitis (HP:0002383) | 1.67101778 |
| 174 | Colitis (HP:0002583) | 1.66405577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.93162400 |
| 2 | PKN2 | 3.62299104 |
| 3 | PRPF4B | 3.15853233 |
| 4 | EEF2K | 3.04236171 |
| 5 | RIPK4 | 3.02791508 |
| 6 | TTN | 2.75274653 |
| 7 | LATS2 | 2.57842254 |
| 8 | CDK12 | 2.52014337 |
| 9 | ICK | 2.39541404 |
| 10 | MAP3K10 | 2.31112059 |
| 11 | SIK1 | 2.30316741 |
| 12 | LATS1 | 2.28709031 |
| 13 | GRK6 | 2.23736427 |
| 14 | TAOK2 | 2.22477140 |
| 15 | MAP3K3 | 2.22107041 |
| 16 | PRKD3 | 2.12174972 |
| 17 | MAP4K1 | 2.06319255 |
| 18 | NEK1 | 1.87955558 |
| 19 | RIPK1 | 1.84966839 |
| 20 | ERN1 | 1.82195480 |
| 21 | TAOK1 | 1.72482474 |
| 22 | PDK3 | 1.66055067 |
| 23 | PDK4 | 1.66055067 |
| 24 | PDGFRA | 1.66018395 |
| 25 | IRAK4 | 1.65130988 |
| 26 | PTK6 | 1.57377626 |
| 27 | SMG1 | 1.52972618 |
| 28 | MAP3K13 | 1.52209727 |
| 29 | FGR | 1.50576076 |
| 30 | FES | 1.47474223 |
| 31 | ZAP70 | 1.45003103 |
| 32 | SIK2 | 1.44104290 |
| 33 | CSK | 1.44103014 |
| 34 | LMTK2 | 1.43487186 |
| 35 | TYK2 | 1.42270734 |
| 36 | BLK | 1.40207751 |
| 37 | KSR2 | 1.39429063 |
| 38 | EPHA2 | 1.38791614 |
| 39 | PHKG1 | 1.37951636 |
| 40 | PHKG2 | 1.37951636 |
| 41 | PAK4 | 1.36302133 |
| 42 | ALK | 1.35566819 |
| 43 | TNK2 | 1.30904738 |
| 44 | TYRO3 | 1.27372187 |
| 45 | MTOR | 1.26037157 |
| 46 | DMPK | 1.25357103 |
| 47 | PAK6 | 1.22306769 |
| 48 | STK38 | 1.20549997 |
| 49 | SGK3 | 1.19747195 |
| 50 | MAPKAPK3 | 1.17961340 |
| 51 | NEK2 | 1.17247911 |
| 52 | JAK3 | 1.13637652 |
| 53 | BMX | 1.13335312 |
| 54 | IKBKE | 1.10203929 |
| 55 | BCKDK | 1.09755949 |
| 56 | MAP3K9 | 1.07824464 |
| 57 | MAP3K6 | 1.06925828 |
| 58 | HCK | 1.06014786 |
| 59 | CAMK1G | 1.03521571 |
| 60 | CAMK1D | 1.02529180 |
| 61 | MAP3K5 | 1.01022179 |
| 62 | TBK1 | 0.99483262 |
| 63 | SIK3 | 0.99312682 |
| 64 | MAPK12 | 0.93015049 |
| 65 | PTK2 | 0.90310944 |
| 66 | SYK | 0.89894159 |
| 67 | JAK2 | 0.88308420 |
| 68 | KSR1 | 0.88101726 |
| 69 | RET | 0.87804674 |
| 70 | BTK | 0.87162752 |
| 71 | MAP3K14 | 0.85972982 |
| 72 | DDR2 | 0.84890299 |
| 73 | MAP3K11 | 0.80315924 |
| 74 | PAK2 | 0.80259191 |
| 75 | PRKAA1 | 0.79555247 |
| 76 | LRRK2 | 0.79367282 |
| 77 | SGK2 | 0.77450139 |
| 78 | HIPK2 | 0.77080149 |
| 79 | IRAK3 | 0.77005740 |
| 80 | CDK4 | 0.76863625 |
| 81 | TESK1 | 0.76436969 |
| 82 | EIF2AK1 | 0.76261805 |
| 83 | MAP3K7 | 0.75397955 |
| 84 | IRAK2 | 0.73952835 |
| 85 | SCYL2 | 0.73264790 |
| 86 | PAK3 | 0.72987615 |
| 87 | MAP3K8 | 0.72365479 |
| 88 | STK38L | 0.71644448 |
| 89 | MAPK11 | 0.71280559 |
| 90 | EPHB1 | 0.70513134 |
| 91 | EPHB2 | 0.70386456 |
| 92 | STK4 | 0.68231290 |
| 93 | PDK1 | 0.67857141 |
| 94 | PIM1 | 0.67526748 |
| 95 | CDK6 | 0.67413453 |
| 96 | DYRK1B | 0.67184979 |
| 97 | MAP2K2 | 0.66115966 |
| 98 | STK3 | 0.65329581 |
| 99 | SGK494 | 0.64950171 |
| 100 | SGK223 | 0.64950171 |
| 101 | CAMK4 | 0.64346292 |
| 102 | FER | 0.62212931 |
| 103 | STK10 | 0.61976820 |
| 104 | PDK2 | 0.61730877 |
| 105 | RPS6KB2 | 0.60588329 |
| 106 | PIK3CG | 0.59143989 |
| 107 | CAMKK1 | 0.59141290 |
| 108 | MARK2 | 0.58733452 |
| 109 | CDC42BPA | 0.58616623 |
| 110 | FGFR3 | 0.58581115 |
| 111 | YES1 | 0.58117501 |
| 112 | DAPK2 | 0.58107916 |
| 113 | WNK4 | 0.57874941 |
| 114 | IRAK1 | 0.55497829 |
| 115 | NTRK1 | 0.54265356 |
| 116 | PRKD1 | 0.54254764 |
| 117 | PDGFRB | 0.54154294 |
| 118 | EPHA3 | 0.53942154 |
| 119 | MAP2K1 | 0.53483445 |
| 120 | WNK1 | 0.51773618 |
| 121 | CDK19 | 0.51730675 |
| 122 | JAK1 | 0.51158868 |
| 123 | RPS6KA2 | 0.50730432 |
| 124 | RAF1 | 0.50553915 |
| 125 | LYN | 0.49389745 |
| 126 | ERBB2 | 0.48233460 |
| 127 | RPS6KC1 | 0.47588970 |
| 128 | RPS6KL1 | 0.47588970 |
| 129 | STK11 | 0.46999757 |
| 130 | AKT2 | 0.46789783 |
| 131 | MAP2K3 | 0.46632826 |
| 132 | PTK2B | 0.46558163 |
| 133 | MAP3K2 | 0.45806111 |
| 134 | PRKCH | 0.45098401 |
| 135 | FGFR4 | 0.44839651 |
| 136 | MET | 0.44586011 |
| 137 | RPS6KA1 | 0.43985453 |
| 138 | CSNK1D | 0.43233119 |
| 139 | ILK | 0.43108529 |
| 140 | GRK5 | 0.42652809 |
| 141 | DYRK3 | 0.42388846 |
| 142 | PRKAA2 | 0.42029543 |
| 143 | CDC7 | 0.40807082 |
| 144 | MAPK7 | 0.40158710 |
| 145 | BRD4 | 0.39843758 |
| 146 | TTK | 0.39377836 |
| 147 | FGFR1 | 0.38387810 |
| 148 | FYN | 0.38183429 |
| 149 | FLT3 | 0.37759936 |
| 150 | PDPK1 | 0.37523978 |
| 151 | MARK3 | 0.37277080 |
| 152 | OBSCN | 0.35541630 |
| 153 | MAP3K1 | 0.32329483 |
| 154 | MAP2K4 | 0.32119072 |
| 155 | PRKD2 | 0.31697020 |
| 156 | TESK2 | 0.31663894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85455343 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.79535310 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.73275902 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66302209 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.42308707 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12875577 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08106747 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.99890965 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.87688263 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86563740 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82367164 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74867652 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61500251 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57670832 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56344595 |
| 16 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50851225 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.48323813 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48194863 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45356401 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.45336711 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44561727 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.42535485 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.42513635 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39259787 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38577132 |
| 26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.37080079 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36761598 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35589402 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.34720390 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33193530 |
| 31 | Bladder cancer_Homo sapiens_hsa05219 | 1.31785583 |
| 32 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.29997212 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.27644736 |
| 34 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.27565736 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26555883 |
| 36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.26188698 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25461364 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.25302539 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23682649 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23578531 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23423015 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21215941 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20740304 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.20373259 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18112082 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17953527 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.17078805 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17027989 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.16943660 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.15609831 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12923898 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12896328 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11757875 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.11618066 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10987889 |
| 56 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10811577 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09931028 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 1.08848427 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.08510520 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08274973 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08221742 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07188833 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07020315 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 1.06839120 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 1.06197434 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06018513 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 1.05588502 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05183010 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 1.04853931 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04849875 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.04725585 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04601676 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04343604 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02735493 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02511748 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02043033 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 1.00568044 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00259342 |
| 79 | Glioma_Homo sapiens_hsa05214 | 1.00194247 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99316332 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.99053607 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.97610672 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97011965 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96728119 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96389603 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96024522 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95237858 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90966770 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90856909 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90113406 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88953921 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88816074 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88262243 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88040506 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86992208 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84439134 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.84151983 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81877917 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80005828 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79987045 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79492951 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78802313 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78785448 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.77807659 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77527471 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77346317 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76969417 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.76934589 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75478767 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74375462 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74354673 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.74212819 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73934540 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.72210769 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71223455 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70999546 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70903619 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69792435 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.69629931 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69611827 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69391995 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69162249 |
| 123 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68272333 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65716907 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65294748 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64751154 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64323758 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63205223 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62081151 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60715771 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60461401 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60229000 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59688628 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59425163 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57625868 |
| 136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57115973 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57014976 |
| 138 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56496244 |
| 139 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55715759 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55680490 |
| 141 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54272327 |
| 142 | Gap junction_Homo sapiens_hsa04540 | 0.53960390 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53854661 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53393275 |
| 145 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52247010 |
| 146 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51327924 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51295202 |
| 148 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51248836 |
| 149 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50682152 |
| 150 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49019923 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48050482 |
| 152 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47138393 |
| 153 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46451653 |
| 154 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46274774 |
| 155 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46063894 |
| 156 | Endocytosis_Homo sapiens_hsa04144 | 0.45873627 |
| 157 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45430088 |
| 158 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45181049 |

